Literature DB >> 22071533

Ifenprodil for the treatment of flashbacks in female posttraumatic stress disorder patients with a history of childhood sexual abuse.

Akira Kishimoto, Motonori Kaneko, Yurie Gotoh, Kenji Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22071533     DOI： 10.1016/j.biopsych.2011.10.014

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN： 0006-3223            Impact factor:   13.382


× No keyword cloud information.
  9 in total

Review 1.  Ketamine as a promising prototype for a new generation of rapid-acting antidepressants.

Authors:  Chadi G Abdallah; Lynnette A Averill; John H Krystal
Journal:  Ann N Y Acad Sci       Date:  2015-02-27       Impact factor: 5.691

2.  Old drug ifenprodil, new hope for PTSD with a history of childhood abuse.

Authors:  Kenji Hashimoto; Tsuyoshi Sasaki; Akira Kishimoto
Journal:  Psychopharmacology (Berl)       Date:  2013-04-07       Impact factor: 4.530

3.  Glutamatergic system abnormalities in posttraumatic stress disorder.

Authors:  Daisuke Nishi; Kenji Hashimoto; Hiroko Noguchi; Kei Hamazaki; Tomohito Hamazaki; Yutaka Matsuoka
Journal:  Psychopharmacology (Berl)       Date:  2015-08-22       Impact factor: 4.530

Review 4.  Ketamine as the prototype glutamatergic antidepressant: pharmacodynamic actions, and a systematic review and meta-analysis of efficacy.

Authors:  Caroline Caddy; Giovanni Giaroli; Thomas P White; Sukhwinder S Shergill; Derek K Tracy
Journal:  Ther Adv Psychopharmacol       Date:  2014-04

5.  Potentiation of nerve growth factor-induced neurite outgrowth in PC12 cells by ifenprodil: the role of sigma-1 and IP3 receptors.

Authors:  Tamaki Ishima; Kenji Hashimoto
Journal:  PLoS One       Date:  2012-05-24       Impact factor: 3.240

6.  σ1 receptor ligands control a switch between passive and active threat responses.

Authors:  Andrew J Rennekamp; Xi-Ping Huang; You Wang; Samir Patel; Paul J Lorello; Lindsay Cade; Andrew P W Gonzales; Jing-Ruey Joanna Yeh; Barbara J Caldarone; Bryan L Roth; David Kokel; Randall T Peterson
Journal:  Nat Chem Biol       Date:  2016-05-30       Impact factor: 15.040

Review 7.  Repurposing of CNS drugs to treat COVID-19 infection: targeting the sigma-1 receptor.

Authors:  Kenji Hashimoto
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2021-01-05       Impact factor: 5.270

Review 8.  D-Serine as the gatekeeper of NMDA receptor activity: implications for the pharmacologic management of anxiety disorders.

Authors:  Herman Wolosker; Darrick T Balu
Journal:  Transl Psychiatry       Date:  2020-06-09       Impact factor: 6.222

9.  Ifenprodil for the treatment of methamphetamine use disorder: An exploratory, randomized, double-blind, placebo-controlled trial.

Authors:  Hiroko Kotajima-Murakami; Ayumi Takano; Shinya Hirakawa; Yasukazu Ogai; Daisuke Funada; Yuko Tanibuchi; Eriko Ban; Minako Kikuchi; Hisateru Tachimori; Kazushi Maruo; Takahiro Kawashima; Yui Tomo; Tsuyoshi Sasaki; Hideki Oi; Toshihiko Matsumoto; Kazutaka Ikeda
Journal:  Neuropsychopharmacol Rep       Date:  2022-01-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.